Classification and Evaluation of the Overweight Patient

HDL cholesterol and increased triglycerides), and release

of inflammatory markers such as interleukin 6 (IL-6) and

tumor necrosis factor a (TNF-a) or procoagulant factors such as plasminogen activator inhibitor 1 (PAI-1) (3,4).